Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 7/20 | 0.40 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.40 |
| ▸ | ITPR2 | Q14571 | 3/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.38 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Inositol SCHEMBL8443504 | 0.89 | TAAR1 (0.37) | — | |
| SCHEMBL2768375 | 0.89 | FUCA1 (0.40) | — | |
| Inositol SCHEMBL3079466 | 0.85 | TAAR1 (0.42) | — | |
| Phosphoric Acid SCHEMBL6689741 | 0.83 | TAAR1 (0.41) | — | |
| Inositol SCHEMBL8441010 | 0.81 | TAAR1 (0.37) | — | |
| SCHEMBL23850856 | 0.80 | ALDH1A1 (0.34) | — | |
| Phosphoric Acid SCHEMBL5665038 | 0.77 | TAAR1 (0.41) | — | |
| SCHEMBL55578 | 0.77 | TAAR1 (0.50) | — | |
| Iodide SCHEMBL6625841 | 0.75 | TAAR1 (0.48) | — | |
| Phosphine SCHEMBL9467574 | 0.75 | TAAR1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230048403-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN | SABIN ROBERT (US) | 2023-02-16 | — | — | US | disclosed |
| US-20210038618-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN | SABIN ROBERT (US) | 2021-02-11 | — | — | US | disclosed |
| US-20200078380-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN | SABIN ROBERT (US) | 2020-03-12 | — | — | US | disclosed |
| CN-104313589-A | Micro emulsion type metal anti-rusting liquid and preparation method thereof | SUZHOU CHANGSHENG ELECTROMECHANICAL CO LTD | 2015-01-28 | — | — | CN | disclosed |
| US-8541036-B2 | Synergetic effect of the phytase combination on the hydrolysis of phytic acid | ADISSEO FRANCE S.A.S. (FR) | 2013-09-24 | — | — | US | disclosed |
| WO-2011119136-A1 | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF NEURO-DEGENERATIVE DISEASES AND PROTEIN AGGREGATION DISEASES | SABIN ROBERT (US) | 2011-09-29 | — | — | WO | disclosed |
| CN-101263226-B | Debaryomyces carinii phytase | ADISSEO FRANCE SAS | 2011-08-17 | — | — | CN | disclosed |
| US-20110091440-A1 | Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases | SABIN ROBERT | 2011-04-21 | — | — | US | disclosed |
| US-20100278965-A1 | Synergetic Effect of the Phytase Combination on the Hydrolysis of Phytic Acid | ADISSEO FRANCE S.A.S. (FR) | 2010-11-04 | — | — | US | disclosed |
| US-20100249073-A1 | Prophylactic and therapeutic treatment of Alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein | SABIN ROBERT | 2010-09-30 | — | — | US | disclosed |
| CN-101263226-A | Debaryomyces castellii phytase | ADISSEO FRANCE SAS (FR) | 2008-09-10 | — | — | CN | disclosed |
| EP-1910531-A1 | SYNERGISTIC EFFECT OF THE COMBINATION OF PHYTASES ON HYDROLYSIS OF PHYTIC ACID | Adisseo France S.A.S. (FR) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007006952-A1 | SYNERGISTIC EFFECT OF THE COMBINATION OF PHYTASES ON HYDROLYSIS OF PHYTIC ACID | ADISSEO FRANCE S.A.S. (FR) | 2007-01-18 | — | — | WO | disclosed |
| US-5217959-A | Method of treating multiple sclerosis with phytic acid | JARIWALLA, RAXIT | 1993-06-08 | — | — | US | disclosed |
| US-5206226-A | Method of treatment of Parkinsons's disease using phytic acid | SABIN ROBERT (US) | 1993-04-27 | — | — | US | disclosed |
| US-5112814-A | Method of treatment of Parkinson's disease using phytic acid | SABIN ROBERT (US) | 1992-05-12 | — | — | US | disclosed |
| EP-0420428-A2 | Mehod of treatment of rheumatoid arthritis using phytic acid | Sabin, Robert (US) | 1991-04-03 | — | — | EP | disclosed |
| US-4952396-A | OR SALTS OR HYDROLYZATES; ORAL ADMINISTRATION | LINUS PAULING INSTITUTE OF SCIENCE & MEDICINE (US) | 1990-08-28 | — | — | US | disclosed |
| US-4847082-A | Method of treatment of Alzheimer's disease using phytic acid | Sabin, Robert (US) | 1989-07-11 | — | — | US | disclosed |
| US-4758430-A | Method of treatment of Alzheimer's disease using phytic acid | SABIN ROBERT (US) | 1988-07-19 | — | — | US | disclosed |